Lupin has announced receiving FDA approval to market norgestimate and ethinyl estradiol tablets in the US market. The tablets are used to prevent pregnancy. The drug is a generic version of Janssen Pharmaceuticals’ Ortho-Cyclen 28 tablets. The drug will be manufactured at Lupin’s Pithampur facility. Last year, Janssen’s Ortho-Cyclen tablets had US sales worth $178.2 million. Lupin is looking to expand its generic offerings in the US market.